WHO Grade 3 Glioma — Trials

WHO Grade 3 Glioma — Trials · CancerIndex

Clinical trials

Registered studies

258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 57
Recruiting: 32
Ph III recruiting: 2
Growth YoY: —
Industry share: 11%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (53)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06241391	Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas	unknown	N/A	35	All India Institute of Medical Sciences, BhubaneswarOTHER	1	Feb 8, 2024	clinicaltrials
NCT02795364	Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas	unknown	N/A	50	Huashan HospitalOTHER	0	Jun 10, 2016	clinicaltrials